logo
Therapy for hepatitis C genotype 3: moving forward
Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings
Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis
Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study
Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus forms
Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B
Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection
Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection
Hepatic involvement in congenital cytomegalovirus infection – infrequent yet significant